Why Aren't Doctors Prescribing Eli Lilly's and Regeneron's COVID-19 Treatments?
Despite gaining emergency use authorizations from the Food and Drug Administration (FDA) over a month ago, many doses of COVID-19 antibody treatments from Eli Lilly (NYSE: LLY) and Regeneron Pharmaceuticals (NASDAQ: REGN) have gone unused. In this video from Motley Fool Live, recorded on Dec. 21, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the reasons for why the antibody drugs are being underutilized.
Source Fool.com
